These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

503 related articles for article (PubMed ID: 17653801)

  • 1. A systematic review and meta-analysis of the randomized controlled trials on adjuvant intraperitoneal chemotherapy for resectable gastric cancer.
    Yan TD; Black D; Sugarbaker PH; Zhu J; Yonemura Y; Petrou G; Morris DL
    Ann Surg Oncol; 2007 Oct; 14(10):2702-13. PubMed ID: 17653801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgery combined with intraoperative hyperthermic intraperitoneal chemotherapy (IHIC) for gastric cancer: a systematic review and meta-analysis of randomised controlled trials.
    Mi DH; Li Z; Yang KH; Cao N; Lethaby A; Tian JH; Santesso N; Ma B; Chen YL; Liu YL
    Int J Hyperthermia; 2013; 29(2):156-67. PubMed ID: 23418917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison different methods of intraoperative and intraperitoneal chemotherapy for patients with gastric cancer: a meta-analysis.
    Huang JY; Xu YY; Sun Z; Zhu Z; Song YX; Guo PT; You Y; Xu HM
    Asian Pac J Cancer Prev; 2012; 13(9):4379-85. PubMed ID: 23167347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upper abdominal stop-flow perfusion as a neo and adjuvant hypoxic regional chemotherapy for resectable gastric carcinoma. A prospective randomized clinical trial.
    Lygidakis NJ; Sgourakis G; Aphinives P
    Hepatogastroenterology; 1999; 46(27):2035-8. PubMed ID: 10430393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benefits of hyperthermic intraperitoneal chemotherapy for patients with serosal invasion in gastric cancer: a meta-analysis of the randomized controlled trials.
    Sun J; Song Y; Wang Z; Gao P; Chen X; Xu Y; Liang J; Xu H
    BMC Cancer; 2012 Nov; 12():526. PubMed ID: 23153379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraperitoneal chemotherapy in advanced gastric cancer. Meta-analysis of randomized trials.
    Coccolini F; Cotte E; Glehen O; Lotti M; Poiasina E; Catena F; Yonemura Y; Ansaloni L
    Eur J Surg Oncol; 2014 Jan; 40(1):12-26. PubMed ID: 24290371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The 30-year experience-A meta-analysis of randomised and high-quality non-randomised studies of hyperthermic intraperitoneal chemotherapy in the treatment of gastric cancer.
    Desiderio J; Chao J; Melstrom L; Warner S; Tozzi F; Fong Y; Parisi A; Woo Y
    Eur J Cancer; 2017 Jul; 79():1-14. PubMed ID: 28456089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neoadjuvant and adjuvant chemotherapy of locally advanced stomach cancer.
    Morant R
    Onkologie; 2001 Apr; 24(2):116-21. PubMed ID: 11441289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A systematic overview of chemotherapy effects in gastric cancer.
    Janunger KG; Hafström L; Nygren P; Glimelius B;
    Acta Oncol; 2001; 40(2-3):309-26. PubMed ID: 11441938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous chemotherapy for resected gastric cancer: meta-analysis of randomized controlled trials.
    Hu JK; Chen ZX; Zhou ZG; Zhang B; Tian J; Chen JP; Wang L; Wang CH; Chen HY; Li YP
    World J Gastroenterol; 2002 Dec; 8(6):1023-8. PubMed ID: 12439918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effectiveness of precautionary chemotherapy in gastric cancer].
    Rimassa L; Campagnoli E; Biancofiore G
    Tumori; 2000; 86(5 Suppl 2):S5-13. PubMed ID: 11195303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review of adjuvant therapy for resected primary gastric cancer with an update on Taegu's phase III trial with intraperitoneal chemotherapy.
    Yu W
    Eur J Surg Oncol; 2006 Aug; 32(6):655-60. PubMed ID: 16618532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Application of hyperthermic intraoperative intraperitoneal chemotherapy in patients with gastric cancer].
    Zhang GY; Chen XC; Pan K; Xia LG; Zuo M; Zheng T
    Zhonghua Wei Chang Wai Ke Za Zhi; 2007 Jul; 10(4):362-4. PubMed ID: 17659464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant intraperitoneal chemotherapy for the treatment of gastric cancer at risk for peritoneal carcinomatosis: A systematic review.
    Feingold PL; Kwong ML; Davis JL; Rudloff U
    J Surg Oncol; 2017 Feb; 115(2):192-201. PubMed ID: 27878811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Stomach carcinoma. Optimizing therapy by neoadjuvant or adjuvant therapy?].
    Rosen H
    Zentralbl Chir; 1999; 124(5):387-93. PubMed ID: 10420523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benefit of adjuvant chemotherapy for resectable gastric cancer: a meta-analysis.
    ; Paoletti X; Oba K; Burzykowski T; Michiels S; Ohashi Y; Pignon JP; Rougier P; Sakamoto J; Sargent D; Sasako M; Van Cutsem E; Buyse M
    JAMA; 2010 May; 303(17):1729-37. PubMed ID: 20442389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Progress in prophylatic hyperthermic intraperitoneal chemotherapy for advanced gastric carcinoma].
    Chen X; Luo J; Liu H; Chen Y; Hu Y; Li T; Lin T; Zhu Y; Zhao M; Chen H; Li G; Yu J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 May; 21(5):593-599. PubMed ID: 29774943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant and neoadjuvant therapy for gastric cancer.
    Kelsen DP
    Semin Oncol; 1996 Jun; 23(3):379-89. PubMed ID: 8658222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Meta-analysis of adjuvant chemotherapy on prognosis for gastric cancer patients after D2 dissection].
    Xia GG; Zhang CH; Wei ZW; Wu Y; He YL
    Zhonghua Wai Ke Za Zhi; 2013 May; 51(5):447-51. PubMed ID: 23958170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retrospective analysis of adjuvant intraperitoneal chemotherapy effect prognosis of resectable gastric cancer.
    Shi C; Yang B; Chen Q; Yang J; Fan N
    Oncology; 2011; 80(5-6):289-95. PubMed ID: 21778768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.